Cargando…

Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity

BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Képes, Z., Aranyi, Cs., Forgács, A., Nagy, F., Kukuts, K., Hascsi, Zs., Esze, R., Somodi, S., Káplár, M., Varga, J., Emri, M., Garai, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218076/
https://www.ncbi.nlm.nih.gov/pubmed/34181137
http://dx.doi.org/10.1186/s41824-021-00097-z
_version_ 1783710715379449856
author Képes, Z.
Aranyi, Cs.
Forgács, A.
Nagy, F.
Kukuts, K.
Hascsi, Zs.
Esze, R.
Somodi, S.
Káplár, M.
Varga, J.
Emri, M.
Garai, I.
author_facet Képes, Z.
Aranyi, Cs.
Forgács, A.
Nagy, F.
Kukuts, K.
Hascsi, Zs.
Esze, R.
Somodi, S.
Káplár, M.
Varga, J.
Emri, M.
Garai, I.
author_sort Képes, Z.
collection PubMed
description BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individuals. METHODS: In our prospective study, 51 patients with controlled T2DM (ages 50.6 ± 8.0 years) and 45 non-DM obese participants (ages 52.0 ± 9.6 years) were enrolled. Glucose levels measured before PET/CT examination (pre-PET glucose) as well as laboratory parameters assessing glucose and lipid status were determined. NeuroQ application (NeuroQ(TM) 3.6, Syntermed, Philips) was used to evaluate regional brain metabolic differences. [(18)F]FDG PET/CT (AnyScan PC, Mediso) scans, estimating brain metabolism, were transformed to MNI152 brain map after T1 registration and used for SPM-based group comparison of brain metabolism corrected for pre-PET glucose, and correlation analysis with laboratory parameters. RESULTS: NeuroQ analysis did not reveal significant regional metabolic defects in either group. Voxel-based group comparison revealed significantly (P(FWE)<0.05) decreased metabolism in the region of the precuneus and in the right superior frontal gyrus (rSFG) in the diabetic group as compared to the obese patients. Data analysis corrected for pre-PET glucose level showed a hypometabolic difference only in the rSFG in T2DM. Voxel-based correlation analysis showed significant negative correlation of the metabolism in the following brain regions with pre-PET glucose in diabetes: precuneus, left posterior orbital gyrus, right calcarine cortex and right orbital part of inferior frontal gyrus; whilst in the obese group only the right rolandic (pericentral) operculum proved to be sensitive to pre-PET glucose level. CONCLUSIONS: To our knowledge, this is the first study to perform pre-PET glucose level corrected comparative analysis of brain metabolism in T2DM and obesity. We also examined the pre-PET glucose level dependency of regional cerebral metabolism in the two groups separately. Large-scale future studies are warranted to perform further correlation analysis with the aim of determining the effects of metabolic disturbances on brain metabolism.
format Online
Article
Text
id pubmed-8218076
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82180762021-06-24 Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity Képes, Z. Aranyi, Cs. Forgács, A. Nagy, F. Kukuts, K. Hascsi, Zs. Esze, R. Somodi, S. Káplár, M. Varga, J. Emri, M. Garai, I. Eur J Hybrid Imaging Original Article BACKGROUND: Metabolic syndrome and its individual components lead to wide-ranging consequences, many of which affect the central nervous system. In this study, we compared the [(18)F]FDG regional brain metabolic pattern of participants with type 2 diabetes mellitus (T2DM) and non-DM obese individuals. METHODS: In our prospective study, 51 patients with controlled T2DM (ages 50.6 ± 8.0 years) and 45 non-DM obese participants (ages 52.0 ± 9.6 years) were enrolled. Glucose levels measured before PET/CT examination (pre-PET glucose) as well as laboratory parameters assessing glucose and lipid status were determined. NeuroQ application (NeuroQ(TM) 3.6, Syntermed, Philips) was used to evaluate regional brain metabolic differences. [(18)F]FDG PET/CT (AnyScan PC, Mediso) scans, estimating brain metabolism, were transformed to MNI152 brain map after T1 registration and used for SPM-based group comparison of brain metabolism corrected for pre-PET glucose, and correlation analysis with laboratory parameters. RESULTS: NeuroQ analysis did not reveal significant regional metabolic defects in either group. Voxel-based group comparison revealed significantly (P(FWE)<0.05) decreased metabolism in the region of the precuneus and in the right superior frontal gyrus (rSFG) in the diabetic group as compared to the obese patients. Data analysis corrected for pre-PET glucose level showed a hypometabolic difference only in the rSFG in T2DM. Voxel-based correlation analysis showed significant negative correlation of the metabolism in the following brain regions with pre-PET glucose in diabetes: precuneus, left posterior orbital gyrus, right calcarine cortex and right orbital part of inferior frontal gyrus; whilst in the obese group only the right rolandic (pericentral) operculum proved to be sensitive to pre-PET glucose level. CONCLUSIONS: To our knowledge, this is the first study to perform pre-PET glucose level corrected comparative analysis of brain metabolism in T2DM and obesity. We also examined the pre-PET glucose level dependency of regional cerebral metabolism in the two groups separately. Large-scale future studies are warranted to perform further correlation analysis with the aim of determining the effects of metabolic disturbances on brain metabolism. Springer International Publishing 2021-02-17 /pmc/articles/PMC8218076/ /pubmed/34181137 http://dx.doi.org/10.1186/s41824-021-00097-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Képes, Z.
Aranyi, Cs.
Forgács, A.
Nagy, F.
Kukuts, K.
Hascsi, Zs.
Esze, R.
Somodi, S.
Káplár, M.
Varga, J.
Emri, M.
Garai, I.
Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title_full Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title_fullStr Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title_full_unstemmed Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title_short Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
title_sort glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218076/
https://www.ncbi.nlm.nih.gov/pubmed/34181137
http://dx.doi.org/10.1186/s41824-021-00097-z
work_keys_str_mv AT kepesz glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT aranyics glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT forgacsa glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT nagyf glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT kukutsk glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT hascsizs glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT eszer glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT somodis glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT kaplarm glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT vargaj glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT emrim glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity
AT garaii glucoseleveldependentbrainhypometabolismintype2diabetesmellitusandobesity